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Purpose: The objective of this study is to develop a facile tool for the absolute detection and 
quantification of nucleic acid transcripts, using a gold nanoparticle-based optical biosensor. 
Topoisomerase 1 (TOP1) and tyrosyl DNA phosphodiesterase 2 (TDP2) were among the nucleic 
acid transcripts of choice due to their role as genomic instability biomarkers and their implication 
in various cancers and neurologic disorders. This opens the door to develop a simple tool that 
can be used for diagnosing and monitoring treatment response for such diseases, overcoming 
the requirements for high cost, time, and complexity of the existing technologies for the absolute 
quantification of transcripts of interest.
Materials and methods: The TOP1 and TDP2 mRNA transcripts were first captured spe-
cifically using magnetic nanoparticles that were functionalized with TOP1- and TDP2-specific 
probes, respectively. The captured mRNA was then directly detected and quantified using the 
gold aggregating gold (GAG) assay, without the need for amplification as in existing technolo-
gies used for the quantification of transcripts.
Results: A linear correlation exists between the GAG assay and the qPCR for the quantification of 
the TOP1 and TDP2 mRNA transcripts (101–104 copies). The detection limit of the GAG assay in 
mRNA quantification was up to 10 copies per reaction. Wild-type and TDP2-deficient cell lines con-
firmed the assay specificity and reproducibility in distinguishing between different transcripts.
Conclusion: The GAG assay can be utilized as an inexpensive, rapid, simple, and sensitive 
tool for the absolute quantification of RNA for different applications, instead of the laborious, 
expensive, and sophisticated real-time PCR.
Keywords: gold aggregating gold, TOP1, TDP2, magnetic nanoparticles, RNA extraction, 
genomic instability, neurodegenerative diseases, tumor markers
Introduction
An efficient healthcare system is dependent on three main pillars: patients (disease), 
efficient and affordable diagnosis, as well as rapid and precise clinical decisions. 
Molecular diagnostics and particularly, nucleic acid testing, lay a solid foundation in 
effective disease management and modern healthcare strategies. In addition, advances 
in molecular diagnostic technologies have had a great impact on establishing the 
rapidly evolving pharmacogenomics field, resulting in the development of the era of 
personalized medicine and overall improvement in the healthcare system.1
DNA damage plays a significant role in cellular dysfunction and death. Defects in 
the DNA repair pathways result in genomic instability. In replicating cells, this could 
lead to cellular transformation, eventually leading to cancer development. On the 
other hand, in nonreplicating cells such as neuronal tissue, a consequence of loss of 
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genomic integrity is apoptosis leading to neurodegenerative 
disorders such as Alzheimer’s disease and Parkinson’s 
disease.2,3 Topoisomerases (TOP) and tyrosyl DNA phos-
phodiesterases (TDP) are among the DNA repair players 
that play a fundamental role in regulating gene transcription, 
DNA replication, recombination, and repair through different 
mechanisms.4 Failure in the activities of these proteins results 
in protein-linked DNA breaks (PDBs), ultimately leading to 
neurodegenerative diseases and cancers.5,6
Patients with neurologic disorders such as intellectual 
disability, seizures, and ataxia have mutations in TDP2. 
As a result, TDP2 expression levels are affected, leading 
to abortive TOP2 activity and increased hypersensitivity to 
TOP2-induced double-stranded breaks.7 Moreover, TOP1 is 
inevitability required for proper synaptic function and regu-
lates the levels of multiple synaptic proteins and, thereby, its 
dysfunction has a negative impact on the synaptic activity.8 
In our recent publication, we have revealed that TOP1- 
mediated PDBs and R-loops lead to genomic instability in 
mice neurons, human cells, and in spinal cord tissues of 
patients suffering from amyotrophic lateral sclerosis and 
frontotemporal dementia.9 Furthermore, TDP1 expression 
was recently found to be decreased in spinocerebellar ataxia 
as a result of the downregulation UCHL3.10 Therefore, TOP1 
and TDP2 transcripts level can be utilized as potential bio-
markers for many neurodegenerative disorders.
On the other hand, TOP1 gene expression can be used 
as an early biomarker for predicting the response to TOP1-
targeting chemotherapeutics.4 A significant correlation was 
found to exist in various colon and breast cancer cell lines 
between TOP1 expression and the sensitivity to SN-38, the 
active metabolite of the TOP1 poison, irinotecan.11–13 In addi-
tion, TDP2 is considered to be a potential biomarker of sen-
sitivity to anticancer drugs such as etoposide, doxorubicin, 
and bicalutamide.14 TDP2 depletion in A549 and H460 lung 
cancer cell lines as well as chicken DT40 cells increased 
the sensitivity of the cells to etoposide.5,15,16 Moreover, 
mutant-p53-dependent overexpression of TDP2 has been 
implicated in cellular resistance to etoposide in lung cancer 
cells.17 Furthermore, we have recently shown that TDP1 
expression is increased in rhabdomyosarcoma as a result 
of the upregulation of UCHL3.10 As a result, the expression 
levels of TOP1 and TDP2 can be measured and utilized as a 
potential biomarker in various cancers to predict and monitor 
patients’ response to different chemotherapeutics.
Sensitive and precise measurement of the mRNA tran-
scripts expression level is of pivotal importance in enhancing 
our understanding to the cellular dogma, leading ultimately to 
accurate diagnosis and, hence, allowing physicians to make 
more informed clinical decisions. This opens the door for the 
development of more personalized therapeutic approaches, 
maximizing patients’ benefit and overcoming the side effects 
and drawbacks of the current conventional therapy.18
Among the tools used for relative and absolute quan-
tification of mRNA are Northern blotting,19,20 RNA in situ 
hybridization,21,22 nuclease protection assays,23 and real-time 
PCR.24–26 Despite the high sensitivity and specificity of the 
aforementioned techniques, especially the latter, they are 
expensive, laborious, and require trained personnel and ade-
quately equipped laboratories. In addition, mRNA absolute 
quantification is a multistep procedure that requires serially 
diluted standards to generate a standard curve. The standard 
could be double- or single-stranded DNA, or cRNA, which 
has the same sequence as the target RNA.27 Although DNA 
standards have the advantage of being more stable than RNA 
standards and exhibit a wider dynamic range, they cannot 
be used for one-step real-time PCR due to the lack of avail-
ability of a control that can measure the efficiency of the 
reverse transcriptase step. Therefore, this necessitates the 
need for alternative approaches for the absolute quantifica-
tion of RNA with an acceptable sensitivity, specificity, and 
cost effectiveness.
In the last two decades, the unique physicochemical 
properties of gold nanoparticles (AuNPs) have been 
exploited considerably in the field of clinical diagnostics.28 
The surface plasmon resonance (SPR) phenomenon of 
AuNPs is responsible for their intense colors, and large 
absorption and cross-sectional scattering properties.29 As a 
result, several colorimetric AuNPs-based detection meth-
ods have been developed.30–34 In our recent publication, we 
have developed a gold aggregating gold (GAG) biosensor 
to detect and quantify the hepatitis C virus RNA in clinical 
serum samples, as an alternative approach to the real-time 
PCR.35
Herein, we have exploited the optical properties of the 
AuNPs for the first time for the absolute quantification of 
unamplified mRNA transcripts using our developed GAG 
approach. TOP1 and TDP2 transcripts from cell lines have 
been extracted and quantified by copy number as well as 
confirmed and validated with qPCR and have demonstrated 
comparable sensitivity and specificity. Our data show that the 
GAG method (Figure 1) could be used efficiently in captur-
ing and quantifying RNA of any origin with high specificity, 
sensitivity, and reproducibility.
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Figure 1 $VFKHPHGHSLFWLQJWKHVWHSVRIVSHFLÀF51$H[WUDFWLRQXVLQJ013VDQGGHWHFWLRQXVLQJJROGDJJUHJDWLQJJROGPHWKRG
Notes:013VIXQFWLRQDOL]HGZLWKWDUJHWVSHFLÀFSUREHDUHPL[HGZLWKWKHWRWDO51$WRVSHFLÀFDOO\FDSWXUHWKHWDUJHW51$A,QWKHSUHVHQFHRIWKHWDUJHWP51$LWLV
FDSWXUHGZLWKWKHSUREHIXQFWLRQDOL]HG013VDQGDIWHUZDVKLQJDQGHOXWLRQWKHSUREHIXQFWLRQDOL]HGFLWUDWHVWDELOL]HG$X13VZHUHDGGHG$IWHUK\EULGL]DWLRQWDNHVSODFH
E\VHTXHQFHFRPSOHPHQWDULW\EHWZHHQWKHSUREHDQGWKHWDUJHWP51$F\VWHDPLQHIXQFWLRQDOL]HG$X13VDUHDGGHG7KHPL[WXUHFRORUUHPDLQVUHGLQFRORUUHÁHFWLQJ
WKHGLVSHUVLRQRIWKH$X13VRQWRWKHWDUJHWP51$LQGLFDWLQJDSRVLWLYHUHVXOWB,QWKHDEVHQFHRIWKHWDUJHWP51$DGGLWLRQRI013VIXQFWLRQDOL]HGZLWKWKHWDUJHW
RNA probe reveals no mRNA after elution. Consequently, no hybridization takes place with the probe-functionalized citrate-stabilized AuNPs and, hence, the addition of 
F\VWHDPLQHIXQFWLRQDOL]HG$X13VUHVXOWVLQDFKDQJHRIWKHVROXWLRQFRORUIURPUHGWREOXH7KLVLVGXHWRWKHLQWHUDFWLRQRIWKHF\VWHDPLQH$X13VZLWKWKHSUREH·VSKRVSKDWH
EDFNERQHHOHFWURVWDWLFDOO\WKHUHE\UHGXFLQJWKHLQWHUSDUWLFOHGLVWDQFHEHWZHHQWKHSUREHIXQFWLRQDOL]HGFLWUDWHVWDELOL]HG$X13VDQGWKHF\VWHDPLQHIXQFWLRQDOL]HG$X13V
UHVXOWLQJLQWKHLUDJJUHJDWLRQDQGLQGLFDWLQJDQHJDWLYHUHVXOW
Abbreviations:$X13VJROGQDQRSDUWLFOHV013VPDJQHWLFQDQRSDUWLFOHV
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Materials and methods
Synthesis and characterization of 
PDJQHWLFQDQRSDUWLFOHV013V
MNPs were prepared by the chemical coprecipitation method 
as described previously with slight modifications.36,37 Briefly, 
ferrous and ferric chloride in a 1:2 molar ratio were mixed 
with deionized water purged with nitrogen gas for 30 min-
utes at 80nC. Then, 28% ammonium hydroxide solution 
was added dropwise to the above mixture under mechanical 
stirring. A black color developed, indicating the formation 
of the magnetite nanoparticles. Stirring and heating were 
continued till the pH was stable at 10. The resulting particles 
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were washed thoroughly with 70% ethanol and deionized 
water at least thrice. The particles were then removed by 
magnetic decantation and dried in an oven overnight at 
50nC. The MNPs were then characterized by high-resolution 
transmission electron microscopy (HR-TEM, JEOL-2100) 
and Fourier-transform infrared spectroscopy (Thermo Sci-
entific Nicolet is-10).
Synthesis and characterization of amino-
functionalized MNPs
Synthesized MNPs were functionalized with aminopropyl 
triethoxy silane (APTES) according to Liu et al38 with slight 
modifications. Briefly, 500 mg of MNPs was dispersed in 
100 mL nitrogen-purged deionized water by sonication, 
and then 2 mL of APTES was added to the above mixture. 
The reaction mixture was heated to 80nC, and stirred 
mechanically for 24 hours. After the reaction was completed, 
the black powder was separated by magnetic decantation, 
washed thoroughly with 70% ethanol and deionized water 
thrice, and then dried in an oven overnight at 50nC. The 
MNPs-APTES were then characterized by HR-TEM (JEOL-
2100) and Fourier-transform infrared spectroscopy (Thermo 
Scientific Nicolet is-10).
Functionalization of MNPs with 
WDUJHWVSHFLÀFSUREHV
Conjugation of TOP1- and TDP2-specific probes to the 
amino-functionalized MNPs was performed using a 
hetero-bifunctional cross-linker, 3-maleimidobenzoic acid 
N-hydroxyl succinimide (MBS). MBS has an NHS ester at 
one end that reacts with the primary amine groups forming 
a stable amide bond and a maleimide group at the other end, 
which reacts with the sulfhydryl groups forming a stable 
thioether linkage. The MNPs-APTES were washed twice 
with dimethyl sulfoxide (DMSO), then MBS dissolved 
in DMSO was added to the nanoparticles and mixed on 
a roller shaker for 1 hour at room temperature. The nano-
particles were then washed twice with DMSO followed by 
coupling buffer (0.1 M phosphate buffer and 0.1 M NaCl, 
pH 7) twice, and collected by a magnet. The particles were 
resuspended in the coupling buffer and the thiol-modified 
probes were added to the suspended particles and allowed 
to react on a roller shaker overnight at room temperature. 
Finally, the solution was removed by magnetic decantation 
and the MNPs functionalized with target-specific probes 
were resuspended in storage buffer (0.01 M phosphate buffer, 
0.1 M NaCl, pH 7.4).
Synthesis and characterization of 
citrate-capped AuNPs
Citrate-capped AuNPs were synthesized according to the 
well-established sodium citrate reduction method of gold (III) 
chloride.39–41 The AuNPs were characterized using HR-TEM 
(JEOL-2100), UV-Vis spectroscopy (Plate Reader, firm ver-
sion 1.32, software version 3.00R2 and serial no 415-1587; 
BMG Labtech, Ortenberg, Germany), and dynamic light 
scattering (Zetasizer Nano ZS90; Malvern Instruments, 
Malvern UK).
Functionalization of the citrate-capped 
$X13VZLWKWDUJHWVSHFLÀFWKLRODWHG
SUREHVQDQRSUREH
TOP1- and TDP2-specific probes were alkanethiol modified 
at their 5` terminus. The probe sequence was complementary 
to the target mRNA. The sequence for TOP1 probe was 
5`AGTCTTCTCGATACTGGTTCCG`3, whereas for TDP2 
probe it was 5`CTAAGTAGGAACACACCCCTC`3. Citrate 
AuNPs were functionalized with each alkanethiol-modified 
mRNA target-specific probe using the salt-aging process.42 
Briefly, 5 nmol of the alkanethiol probe was first lyophilized, 
and then, the disulfide cleavage of the probe was achieved 
by resuspension in 100 ML of 0.1 M dithiothreitol (Sigma 
Aldrich), dissolved in 0.17M phosphate buffer (pH 8), for 
2–3 hours with occasional vortexing, while being wrapped 
in foil. The cleaved probes were then purified using NAP-5 
columns (GE Healthcare Illustra) according to the manufac-
turer’s instructions. The concentration of the probes after 
cleavage was measured using Beer–Lambert law from their 
absorbance at 260 nm. Freshly cleaved probes were then 
added to the AuNP solution with the ratio of ^ 1 OD/mL nano-
particles. After 20 minutes incubation at room temperature, 
phosphate buffer and sodium dodecyl sulfate were added to 
a final concentration of 0.01M and 0.1%, respectively. Then, 
salting process was done by adding three portions of sodium 
chloride solution at 30 minutes intervals to bring the final 
concentration of sodium chloride to 0.3M. The solution was 
incubated overnight with very gentle shaking. Centrifuga-
tion (14,000 rpm for 30 minutes) was performed five times 
to wash and remove the excess probes. The concentration of 
the unconjugated probes was measured in the supernatant to 
calculate their number. The gold pellet was resuspended in 3 
mL of assay buffer (0.01M phosphate, 0.15M NaCl, and 0.1% 
SDS, pH 7.4). The color of the solution containing the func-
tionalized AuNPs was not different from the original AuNPs 
and no aggregation was observed, indicating the efficiency 
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of the conjugation process. The probe-functionalized AuNPs 
were characterized by UV-Vis spectroscopy (Plate Reader 
BMG Lab tech, firm version 1.32, software version 3.00R2 
and serial no 415-1587).
Synthesis and characterization of 
cysteamine-functionalized AuNPs
Cysteamine AuNPs were prepared according to Kim et al43 
with minor modifications. Four hundred microliters of 
0.15M cysteamine solution was added to 30 mL of 0.001M 
HAuCl
4
H
2
O and stirred for 20 minutes. Then 20 ML of 
freshly prepared 0.01M NaBH
4
 solution was added under 
dark conditions, with vigorous stirring, twice, with 20-minute 
intervals. The solution was left to stir vigorously in the dark 
for 6 hours until AuNPs were formed, which were then stored 
at 4nC. The formed nanoparticles were then characterized 
using HR-TEM (JEOL-2100), UV-Vis spectroscopy (Plate 
Reader BMG Lab tech, firm version 1.32, software version 
3.00R2 and serial no 415-1587), and dynamic light scattering 
(Zetasizer Nano ZS90, Malvern Instrument Ltd. UK).
5.2VDQGPRXVHHPEU\RQLFÀEUREODVW
0()FHOOOLQHVSURSDJDWLRQ
RKOs cancer cell lines (Homo sapiens, tissue: colon, 
carcinoma) were purchased from ATCC, LGC Standards, 
Middlesex, UK.44 They were cultured at 37nC and 5% CO
2
 
in RPMI-1640 medium, supplemented with 10% FBS, 
1% L-glutamine, and 1% penicillin/streptomycin. TDP2 
knockout mice and MEF were generated, maintained, and 
genotyped as described previously in our works15,45,46 in an 
outbreed mixed 129 Ola and C57BL/6 background. The use 
of these cell lines was approved by the Institutional Review 
Board at the University of Sussex as per previous publica-
tions and subsequently by the Center of Genomics, Zewail 
City of Science and Technology Committee.
7RWDO51$DQGVSHFLÀFWUDQVFULSWV
extraction
RNeasy mini kit (Qiagen, Cat No: 74106) was used for 
total RNA extraction following manufacturer’s instructions 
and then each transcript was further purified by each target-
specific probe-functionalized MNPs. Approximately 100 
ng of the extracted RNA was denatured by heating at 72nC 
for 2 minutes and then mixed with the functionalized MNPs 
at 1,000 rpm for 15–20 minutes at 60nC. The MNPs were 
then washed with assay buffer (0.01M phosphate buffer, 
0.1 M NaCl, and 0.01% SDS, pH 7.4) which was preheated 
at 50nC and collected at the bottom of the tube by the action 
of a permanent external magnet. This washing step was 
repeated for three times. Elution of the desired target mRNA 
was done by adding deionized water, and heating at 72nC for 
2 minutes then rapidly collecting the MNPs by an external 
magnet. The supernatant containing the target mRNA was 
collected and preserved at 80nC.
GAG assay for mRNA transcripts 
GHWHFWLRQDQGTXDQWLÀFDWLRQ
The assay was performed by mixing 5 ML of the target-
specific nanoprobe with 10 ML of the mRNA sample and 
heating at 95nC for 3 minutes followed by incubating at 
room temperature for 5 minutes. Ten microliters of 1 nM 
cysteamine-functionalized AuNPs was then added to the solu-
tion and mixed well. The solution color was developed imme-
diately and observed by naked eye while mixing. The color 
was stable for ^ 30 minutes, depending on the RNA concentra-
tion. The solutions were scanned spectrophotometrically from 
400 to 750 nm (Plate Reader BMG Lab tech, firm version 
1.32, software version 3.00R2 and serial no 415-1587).
4XDQWLÀFDWLRQRI723DQG7'3P51$
WUDQVFULSWVXVLQJUHDOWLPH3&5
A standard curve was performed using serial dilutions of the 
amplicons generated from the mRNA extracted by the MNPs 
for each target. After mRNA extraction, 4 ML of the mRNA 
was taken for the cDNA reaction (total reaction volume 
40 ML) using hexamer primer by iScript cDNA synthesis kit 
(Biorad, Cat No: 170–8891) according to the manufacturer’s 
instructions. Then, 2 ML of the cDNA reaction was taken 
for the qPCR reaction (QuantStudio Real-Time qPCR) for 
both TOP1 and TDP2 in two different reactions (10 ML total 
reaction volume). Sequences for the primers and details of the 
thermal cycler are described in the supporting information.
4XDQWLÀFDWLRQRI723DQG7'3P51$
WUDQVFULSWVXVLQJ*$*PHWKRG
Quantification of the targets’ transcripts using the GAG 
method was performed by preparing serial dilutions of each 
transcript concentration (101–104 copies/reaction volume), 
and quantified using the GAG assay. The spectral absorbance 
for each concentration was scanned spectrophotometrically 
in duplicate, and the ratio of the nonaggregated nanoparticles 
at wavelength (L) of 530 nm to the aggregated nanoparticles 
at L of 620 nm (A
530
/A
620
) was recorded and used to generate 
the standard curve, in which the A
530
/A
620
 ratio was plotted 
against the log RNA concentration.
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Results and discussion
Synthesis, functionalization, and 
characterization of MNPs
The MNPs were synthesized according to the coprecipita-
tion method and were then functionalized with an amino 
functional group through silanization with 3-APTES. Func-
tionalization of MNPs with amino groups was confirmed 
by their Fourier transform infrared spectra. The band at 
1,050 cm1 corresponds to the vibration of Si-O structure. The 
band at 2,900 cm1 reveals the anchored propyl group of the 
APTES. The N-H bending and stretching vibration of the free 
amino groups is shown at 1,620 cm1 and the characteristic 
fork-shaped band at 3,400 cm1. In addition, the MNPs and 
MNPs-APTES were characterized by TEM, which showed 
that functionalization with APTES did not affect their average 
size and particles uniformity and homogeneity (Figure 2).
Synthesis, functionalization, and 
characterization of AuNPs
TEM analysis revealed that the citrate-capped and cysteamine-
functionalized AuNPs were spherical in shape and uniformly 
distributed. The images were then analyzed using Image 
1.41J software package (Wayne Rasband, National Institutes 
of Health USA. http://rsb.info.nih.gov/ij/Java1.6.0_05), to 
determine the size distribution of the particles. The citrate-
capped and cysteamine-functionalized AuNPs had diameters 
of 12o2 and 40o5 nm, respectively (Figure 3). Zeta potential 
of the citrate-capped and the cysteamine-functionalized 
AuNPs were found to be 45.2 and 35.5 mV, respectively 
(Figure S1).
TOP1 and TDP2 transcript-specific nanoprobes were 
synthesized by functionalizing the citrate AuNPs with the 
alkanethiol-modified probes in two separate tubes, utilizing 
the advantage of the formation of a strong covalent bond 
between the thiol functional group and the gold surface.47 
The synthesized nanoprobes were stable against low salt 
concentration and/or positively charged cysteamine-
functionalized AuNPs induced aggregation. The UV-Vis 
spectrum of the as-synthesized citrate AuNPs revealed 
a L
max
 at 520 nm, which was red-shifted to 530 nm after 
being functionalized with the target-specific probes. Fur-
thermore, the cysteamine AuNPs revealed a L
max
 at 527 
nm (Figure 3E). Comparing the spectrum of the citrate 
and cysteamine AuNPs against the nanoprobes spectrum 
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Figure 2 &KDUDFWHUL]DWLRQRIWKH013VDQG013V$37(6XVLQJ7(0DQG)7,5
Notes:A7(0LPDJHVRIPDJQHWLFQDQRSDUWLFOHVB6L]HGLVWULEXWLRQDQDO\]HGIURP7(0LPDJHVRI013VC7(0LPDJHVRI$37(6IXQFWLRQDOL]HG013VD) Size 
GLVWULEXWLRQDQDO\]HGIURP7(0LPDJHVRI$37(6IXQFWLRQDOL]HG013VE) The FTIR spectra of as-synthesized MNPs and MNPs-APTES.
Abbreviations:$37(6DPLQRSURS\OWULHWKR[\VLODQH)7,5)RXULHUWUDQVIRUPLQIUDUHG013VPDJQHWLFQDQRSDUWLFOHV
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Figure 3 &KDUDFWHUL]DWLRQRIWKHDVV\QWKHVL]HGJROGQDQRSDUWLFOHVDQGWKHQDQRSUREHVXVLQJ7(0DQG899LVVSHFWURSKRWRPHWHU
Notes: A 7(0 LPDJHV RI FLWUDWHFDSSHG $X13V B 6L]H GLVWULEXWLRQ DQDO\]HG IURP 7(0 LPDJHV RI FLWUDWHFDSSHG $X13V VKRZLQJ DQ DYHUDJH GLDPHWHU RI  QP 
C7(0LPDJHVRIF\VWHDPLQHIXQFWLRQDOL]HG$X13VD6L]HGLVWULEXWLRQDQDO\]HGIURP7(0LPDJHVRIF\VWHDPLQHIXQFWLRQDOL]HG$X13VVKRZLQJDQDYHUDJHGLDPHWHURI
QPE7KHH[WLQFWLRQVSHFWUDRIWKHDVV\QWKHVL]HGFLWUDWHDQGF\VWHDPLQH$X13VVKRZLQJLmax at 520 and 527 nm, respectively. TOP1 and TDP2 nanoprobes showed 
DVOLJKWUHGVKLIWWRQPZLWKDUHGXFWLRQLQSHDNLQWHQVLW\DQGDQLQFUHDVHLQDEVRUSWLRQDERYHQPFRQÀUPLQJSURSHUIXQFWLRQDOL]DWLRQ
Abbreviations:$X13JROGQDQRSDUWLFOH7'3W\URV\O'1$SKRVSKRGLHVWHUDVH7(0WUDQVPLVVLRQHOHFWURQPLFURVFRS\723WRSRLVRPHUDVH
in Figure 3E, it is obvious that the aggregated popula-
tions of the AuNPs in the nanoprobes extinction spectra 
are slightly higher than the as-synthesized citrate AuNPs, 
confirming the increase in size of the citrate AuNPs after 
functionalization with the probes. The molar concentration 
of the citrate and cysteamine AuNPs was calculated accord-
ing to Liu et al.48 to be about 3.5 and 1 nM, respectively. 
The amount of probes conjugated to the citrate AuNPs 
was calculated according to Hill and Mirkin39 and Hurst 
et al42 to be about 1.2 and 1.3 nmol for the TOP1 and TDP2 
nanoprobes, respectively. Accordingly, about 130 and 115 
probes of TDP2 and TOP1, respectively, were conjugated 
per nanoparticle. This slight difference between the two 
probes in terms of the conjugation amount has shown no 
significant effect on the assay procedures and quantification 
as discussed later.
Quantification using the GAG approach of endogenous 
transcripts is quite challenging, as the detection and quan-
tification is based on a probe of 22 bases long, which may 
increase the probabilities of false positive results. Therefore, 
MNPs functionalized with a target-specific probe have been 
employed herein for enrichment of the RNA pool with the 
target mRNA to minimize false positives and ensure the 
accuracy and the precision of the assay. After magnetic 
extraction of TOP1 and TDP2 transcripts from the human 
colorectal cancer RKO cell lines, a portion of each transcript 
was quantified using the absolute standard curve generated 
by the real-time PCR. Then, serial dilutions of the RNA 
were conducted and measured using the GAG assay. Our 
data indicate a linear correlation between the ratio of absor-
bance at wavelength 530 nm/absorbance at wavelength 
620 nm for the target’s concentrations between 101 and 104 
copies per reaction for both TOP1 and TDP2 (Figure 4). 
These data have been produced blindly at least twice by 
two independent researchers. The data confirm the repro-
ducibility, sensitivity, and specificity of the GAG assay in 
the detection and quantification of any RNA using specific 
probes. The detection limit of the assay has been found to 
be ten copies per reaction. Linear association has been found 
between the GAG method and the real-time PCR for TOP1 
and TDP2 detection/quantification in the range of 101–104 
copies (Figure 5).
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Figure 4 GAG assay spectrum results with TOP1 and TDP2 mRNA transcripts.
Notes:A'LIIHUHQWFRQFHQWUDWLRQVRI723P51$ZHUHGHWHFWHGDQGTXDQWLÀHGE\DVSHFLÀFSUREHXVLQJWKH*$*DVVD\7KHP51$ZDVH[WUDFWHGDQGWKHQWDUJHWHG
E\WKHFRQMXJDWHGQDQRSDUWLFOHV'LIIHUHQW635VZHUHREWDLQHGDFFRUGLQJWRWKH723P51$FRQFHQWUDWLRQFRS\QXPEHU7KHDJJUHJDWLRQEHKDYLRUZDVFRPSDWLEOHZLWK
ERWK635DQGFRQFHQWUDWLRQB$VWDQGDUGFXUYHZDVSHUIRUPHGE\JHWWLQJWKHDEVRUEDQFHUDWLR$
530
/ADJDLQVWWKHORJRIWKHP51$FRQFHQWUDWLRQ$OLQHDUUHODWLRQVKLS
was obtained with R2C'LIIHUHQWFRQFHQWUDWLRQVRI7'3P51$ZHUHWDUJHWHGE\D7'3VSHFLÀFSUREHXVLQJWKH*$*DVVD\DFFRUGLQJWRWKH7'3P51$
FRQFHQWUDWLRQFRS\QXPEHU7KHDJJUHJDWLRQEHKDYLRUZDVFRPSDWLEOHZLWKERWK635DQGFRQFHQWUDWLRQD$VWDQGDUGFXUYHZDVSHUIRUPHGE\SORWWLQJWKHDEVRUEDQFH
UDWLR$
530
/ADJDLQVWWKHORJRIWKHP51$FRQFHQWUDWLRQDQGDOLQHDUUHODWLRQVKLSZDVREWDLQHGZLWK520.9199.
Abbreviations:*$*JROGDJJUHJDWLQJJROG635VXUIDFHSODVPRQUHVRQDQFH7'3W\URV\O'1$SKRVSKRGLHVWHUDVH723WRSRLVRPHUDVH
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Figure 5 GAG assay vs the C
t
 RI UHDOWLPH 3&5 DFFRUGLQJ WR WKH FRS\ QXPEHUV RI A723P51$ DQG B) TDP2 mRNA in RKO cell lines. The absorbance ratio 
$
530
/A) and the CtZHUHSORWWHGYVWKHP51$FRQFHQWUDWLRQFRS\QXPEHU)RUERWKWUDQVFULSWVWKHUHODWLRQEHWZHHQWKHP51$FRQFHQWUDWLRQYVERWKWKH&t and the 
DEVRUEDQFHUDWLRLVLQYHUVHO\SURSRUWLRQDOZKLFKFRQÀUPVWKHVSHFLÀFLW\DQGSUHFLVLRQRIWKH*$*QDQRDVVD\DQGLWVFDSDELOLW\LQFRPSHWLQJZLWKWKHUHDOWLPH3&5IRU51$
DEVROXWHTXDQWLÀFDWLRQ,QFUHDVLQJ51$FRQFHQWUDWLRQUHVXOWVLQGHFUHDVHG&
t
 and increased absorbance ratio and vice versa. The error bars represent the standard error of 
each point.
Abbreviations: C
t
WKUHVKROGF\FOH*$*JROGDJJUHJDWLQJJROG7'3W\URV\O'1$SKRVSKRGLHVWHUDVH
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The melting curves confirming the efficiency and specific-
ity at amplification and the standard curves generated for the 
TOP1 and TDP2 transcripts are shown in Figures S2–S4.
Absorption performance of MNPs 
WRZDUGWDUJHWHGP51$WUDQVFULSWV
The total RNA extract from the cell lines was subjected to 
MNPs-based extraction and the transcript of interest was 
enriched through utilizing the MNPs functionalized with 
the target-specific probe. To investigate the capacity of the 
MNPs in capturing the mRNA of interest, the absorbance at 
260 nm of the total RNA extract, as well as that found in the 
supernatant, washes, and the final elution after subjection to 
the MNPs was measured. The total amount of RNA that was 
found in the final elution was ten times lower than that in 
the starting total RNA extract. This is expected because the 
MNPs functionalized with the target-specific probe selec-
tively capture the transcript of interest mainly.
Furthermore, RT-PCR was also conducted on the afore-
mentioned total RNA, supernatant, washes, and the final elute 
for four mRNA transcripts: TOP1 and TDP2 as well as TOP2 
and TDP1, which are structurally and functionally related 
to both TOP1 and TDP2. Although the final elute contains 
all the four transcripts, the transcript of interest captured by 
the MNPs functionalized with the target-specific probe was 
present in the highest amount. This confirms that the extrac-
tion using the MNPs functionalized with the target-specific 
probe enriches the presence of the target in the final elution. 
Moreover, the loss of the transcript of interest starts from the 
first supernatant (after incubation of the MNPs with the total 
RNA) to the final elute and is for about 20%. This confirms 
that most of the targeted mRNA transcripts captured by the 
MNPs are retained until elution.
*$*DVVD\VSHFLÀFLW\DQGUHSURGXFLELOLW\
validation
To confirm the specificity and reproducibility of the GAG 
assay in distinguishing between different transcripts, the 
assay has been performed on two MEF cell lines, the wild-
type and TDP2 knockout cells (Tdp2/ MEF). Total RNA 
was extracted from the two cell lines in parallel, and then 
extracted using MNPs functionalized with TDP2-specific 
probe. The assay was conducted on the magnetic extracted 
RNA. Positive results were revealed by the GAG method 
for the wild-type MEF cell lines and negative for the Tdp2/ 
MEF cell lines. The extinction spectra and the assay colors 
of the wild-type and Tdp2/ MEFs are shown in Figure 6. 
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Figure 6 'HWHFWLRQRI7'3LQ0()FHOOVXVLQJJROGDJJUHJDWLQJJROGPHWKRG
Notes: A $ SKRWRJUDSK RI WKH ÀQDO UHVXOWV RI WKH *$* DVVD\ FRQGXFWHG RQ
0()ZLOGW\SHDQG7'3GHÀFLHQWFHOO OLQHVDVZHOODVDEODQN QHJDWLYHFRQWURO
7KHUHVXOWVVKRZWKDWWKH$X13VKDYHDJJUHJDWHGDQGWXUQHGEOXHLQERWKWKHEODQN
and Tdp2/0() FHOOVZKLOH WKHUHZDV QR DJJUHJDWLRQREVHUYHG LQ WKHZLOGW\SH
0()FHOOVZLWKWKH$X13VUHPDLQLQJUHG LQFRORU LQGLFDWLQJWKHSUHVHQFHRIWKH
7'3P51$WUDQVFULSWB7KHH[WLQFWLRQVSHFWUDRIWKH$X13VDIWHUFRQGXFWLQJ
the GAG assay on the blank, wild-type, and Tdp2/ 0() FHOOV FRQÀUPLQJ WKH
QRQDJJUHJDWLRQRIWKH$X13VLQWKHZLOGW\SHGXHWRWKHSUHVHQFHRI7'3DQGWKH
DJJUHJDWLRQRIWKH$X13VLQWKHEODQNDQG7GS/ due to the absence of TDP2.
Abbreviations:$X13JROGQDQRSDUWLFOH*$*JROGDJJUHJDWLQJJROG0()PRXVH
HPEU\RQLFÀEUREODVW7'3W\URV\O'1$SKRVSKRGLHVWHUDVH
Further confirmation was obtained by repeating the assay 
at three different passages using three independent biologic 
replicates.
Mechanism of GAG assay
After eluting the RNA transcript, it is added to the nano-
probe and denatured at 95nC for 3 minutes. This is neces-
sary to allow the accessibility of the probes to the RNA 
molecules, through unfolding the RNA tertiary structure. 
As a result, hybridization between the target mRNA and 
the complementary probe occurs and when the mixture is 
subsequently cooled to room temperature, the RNA would 
then refold to adopt a more favorable, thermodynamically 
stable form. The folding of the target mRNA around the spe-
cific nanoprobe stabilizes it against the aggregation induced 
by the addition of the cysteamine-functionalized AuNPs 
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as it results in the formation of multiple layers of RNA. 
Cysteamine-functionalized AuNPs are distributed along the 
RNA molecules, with their positively charged amino groups 
interacting electrostatically with the negatively charged phos-
phate backbone of the target RNA shielding the nanoprobe, 
hence preventing its aggregation. In the absence of the target 
RNA, the positively charged cysteamine-functionalized 
AuNPs would interact with the negatively charged phos-
phate backbone of the probe functionalized on the AuNPs 
(nanoprobe), which would bring them in close proximity, 
resulting in the aggregation of the AuNPs.
Conclusion
In conclusion, we demonstrated the potential of the GAG 
assay as a biosensor designed to specifically detect and 
quantitate endogenous genome stability transcripts that are 
clinically important for both cancer and neurologic disease. 
Our method is useful for diagnosing and monitoring the 
progression of disease and can be used as an indicator for 
response to chemotherapeutic treatment. The developed 
biosensor could compete with the real-time PCR in measur-
ing gene expression with a detection limit of ten copies of 
the specific mRNA target. Moreover, the biosensor has the 
potential in discriminating between the target mRNA in cells 
expressing or not expressing the desired target. The overall 
time of the assay is ^30–45 minutes including the mRNA 
extraction. Moreover, absolute quantification of RNA has 
been achieved without the tedious and labor-intensive real-
time PCR standard curve generation of the RNA target. 
Therefore, the developed biosensor could be used in small 
laboratories in rural areas where sophisticated equipment 
and well-trained personnel are not available.
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Molar concentration calculations
Molar concentration of the citrate-capped and cysteamine-
functionalized AuNPs was calculated using equations A.1 
and A.2, assuming that all the gold ions have been consumed 
in the reaction and the particles are spherical in shape forming 
face-centered cubic (FCC) phase within the AuNPs.1
 
N
D
M
D P 
6
l 3
330.89602 
 
(A.1)
where N is the average number of gold atoms per particle, 
l is the density for FCC gold (19.3 g/cm3), M is the atomic 
weight of gold (197 g/mol), and D is the average diameter, in 
nanometer, for the AuNPs as analyzed from the TEM images.
Then, the molar concentration is calculated according to 
the following equation:
 
C
N
NVN
 total
A  
(A.2)
in which N
total
 is the number of gold nanoparticles in the 
reaction volume, N is the average number of gold atoms 
calculated from equation A.1, whereas V is the volume of the 
reaction solution in liters, and N
A
 is Avogadro’s number.
Characterization of citrate-capped 
DQGF\VWHDPLQHIXQFWLRQDOL]HGJROG
nanoparticles
Zeta potential of the synthesized AuNPs was recorded by zeta 
Sizer. Each sample was measured three times and scanned 
100 times for each measurement, and both mean and SD for 
each sample was calculated. The zeta potential of citrate and 
cysteamine AuNPs is shown in Figure S1.
Generation of absolute standard curves 
IRUTXDQWLÀFDWLRQRI723DQG7'3
WUDQVFULSWVXVLQJUHDOWLPH3&5
For TOP1, the forward primer was 5`GAAGTCCGGC 
ATGATAACAAGG`3, whereas the reverse primer was 
5`AGTCTTCTCGATACTGGTTCCG`3. On the other 
hand, for TDP2, the forward primer was 5`AGCCC 
AAGACCTATGTTGACC`3, whereas the reverse primer 
was 5`CTAAGTAGGAACACACCCCTC`3. The annealing 
temperature was adjusted specifically for each transcript to 
be 57.3nC for TOP1 and 55.3nC for TDP2. The thermal cycler 
for TOP1 was 95nC for 15 seconds, 57.3nC for 60 seconds, 
and 95nC for 15 seconds for 35 cycles, whereas the thermal 
cycler for TDP2 was 95nC for 15 seconds, 55.3nC for 60 
seconds, and 72nC for 20 seconds for 35 cycles.
All the reaction volume for both transcripts was taken and 
run on agarose gel, and the specified band was excised from 
the gel and purified by the QiAquick Gel Extraction Kit (Cat 
No 28706) according to the manufacturer’s instructions. Fur-
ther purification was done for the amplicons using QiAquick 
PCR Purification Kit (Cat No 28104), according to the manu-
facturer’s instructions. These processes were repeated three 
times to get a high yield and concentration of the PCR product 
for both transcripts. The final amplicon concentrations were 
measured using UV at 260 nm, and the copy numbers were 
calculated according to the base pairs of each amplicon to be 
187 and 183 for TOP1 and TDP2, respectively. 
Serial dilutions of the purified amplicons were then 
performed for TOP1 and TDP2 (101–1010), and qPCR with 
the same abovementioned cycling conditions was performed 
for each dilution and standard curves for TOP1 and TDP2 
were generated as shown in Figures S3 and S4, respectively. 
These standard curves were then used for calculating the copy 
numbers of RNA in the nanoassay.
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Figure S3 723VWDQGDUGFXUYHJHQHUDWHGIURPWKHDPSOLFRQVVHULDOGLOXWLRQV
Notes: As shown, C
t
 decreases with increase in copy number, with a linear correlation between the C
t
 and the concentration. R27KH3&5HIÀFLHQF\ZDV
Abbreviation: TOP1, topoisomerase 1.
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Abbreviation: TDP2, tyrosyl DNA phosphodiesterase 2.
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